|
Volumn 21, Issue 19, 2011, Pages 6007-6012
|
Dual pro-drugs of 2′-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus
|
Author keywords
HCV; NS5B; Nucleoside; Nucleotide; Phosphoramidate; Polymerase; ProTide
|
Indexed keywords
2' METHYLGUANOSINE MONOPHOSPHATE;
ANTIVIRUS AGENT;
CARBOXYPEPTIDASE C;
INX 189;
NUCLEOSIDE;
NUCLEOTIDE;
PHOSPHORAMIDIC ACID DERIVATIVE;
PRODRUG;
UNCLASSIFIED DRUG;
ARTICLE;
DRUG CYTOTOXICITY;
DRUG ISOLATION;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG STRUCTURE;
HEPATITIS C;
HEPATITIS C VIRUS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
LIVER CELL;
NONHUMAN;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHOSPHORUS NUCLEAR MAGNETIC RESONANCE;
VIRUS HEPATITIS;
VIRUS INHIBITION;
5'-GUANYLIC ACID;
AMIDES;
AMP DEAMINASE;
ANTIVIRAL AGENTS;
CELL LINE, TUMOR;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
HEPACIVIRUS;
HEPATITIS C;
HUMANS;
HYDROLYSIS;
INHIBITORY CONCENTRATION 50;
MICROBIAL SENSITIVITY TESTS;
MOLECULAR STRUCTURE;
NUCLEOSIDES;
PHOSPHORIC ACIDS;
PHOSPHORYLATION;
PRODRUGS;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
VIRUS REPLICATION;
HEPATITIS C VIRUS;
|
EID: 80052567516
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2011.06.013 Document Type: Article |
Times cited : (16)
|
References (9)
|